Braden Michael Leonard - May 14, 2024 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role
10%+ Owner
Signature
/s/ Braden Michael Leonard
Stock symbol
RPHM
Transactions as of
May 14, 2024
Transactions value $
$639,578
Form type
4
Date filed
5/16/2024, 08:58 AM
Previous filing
May 15, 2024
Next filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPHM Common Stock Purchase $124K +79.3K +3.51% $1.56 2.34M May 14, 2024 Holding of BML Investment Partners, L.P. F1, F2
transaction RPHM Common Stock Purchase $516K +335K +14.33% $1.54 2.67M May 14, 2024 Holding of BML Investment Partners, L.P. F1, F3
holding RPHM Common Stock 1.02M May 14, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F2 Purchased in multiple transactions with a weighted average price of $1.56. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
F3 Purchased in multiple transactions with a weighted average price of $1.54. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.